Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 453 $ 341
Accounts receivable and contract assets, net of allowance for doubtful accounts of $33 million and $25 million, respectively 91 183
Other current assets 77 33
Total current assets 621 557
Property and equipment, net 138 155
Intangible assets not subject to amortization:    
Goodwill (note 5) 2,221 2,527
Trademarks (note 5) 728 980
Intangible assets not subject to amortization 2,949 3,507
Intangible assets subject to amortization, net 221 277
Other assets, at cost, net of accumulated amortization 201 230
Total assets 4,130 4,726
Current liabilities:    
Deferred merchant and other payables 52 170
Deferred revenue 31 62
Accrued liabilities and other current liabilities 149 205
Total current liabilities 232 437
Long-term debt (note 6) 531 353
Deferred income tax liabilities 189 254
Other liabilities 357 381
Total liabilities 1,309 1,425
Redeemable preferred stock, $.01 par value. Authorized shares 50,000,000; issued and outstanding 325,000 shares at September 30, 2020 and 0 at December 31, 2019 (note 7) 370
Equity:    
Additional paid-in capital 251 237
Accumulated other comprehensive earnings (loss), net of taxes (28) (29)
Retained earnings (137) 111
Total stockholders' equity 87 320
Noncontrolling interests in equity of subsidiaries 2,364 2,981
Total equity 2,451 3,301
Commitments and contingencies (note 9)
Total liabilities, redeemable preferred stock and equity 4,130 4,726
Series A    
Equity:    
Common stock value 1 1
Series B    
Equity:    
Common stock value
Series C    
Equity:    
Common stock value